Predictors of Vertebral Compression Fracture Following Stereotactic Body Radiation Therapy in SINS Potentially Unstable Spinal Metastases [0.03%]
SINS潜在不稳脊柱转移瘤立体定向体部放射治疗后的椎体压缩性骨折预测因素分析
Laura Burgess,Eshetu G Atenafu,Kang Liang Zeng et al.
Laura Burgess et al.
Purpose: The Spinal Instability in Neoplasia Score (SINS) is the gold standard to determine if the metastatically involved spine is stable, potentially unstable, or frankly unstable. In potentially unstable spines, clarit...
Deformable dose mapping and accumulation techniques for stereotactic body radiotherapy (SBRT) of lung cancers [0.03%]
立体定向体放射治疗(LC-SBRT)的可变形剂量映射和累积技术研究
Indrin J Chetty,Hualiang Zhong
Indrin J Chetty
Deformable dose mapping (DDM) and accumulation (DDA) are essential tools in lung cancer stereotactic body radiation therapy (SBRT). Here we provide a critical review of deformable image registration (DIR)-based dose mapping and accumulation...
Treatment With Stereotactic Ablative Radiotherapy for patients with Up to 5 Oligometastatic cancer lesions: Long-Term Outcomes of the Nonrandomized Population-Based Phase 2 SABR-5 Clinical Trial [0.03%]
立体定向消融放射治疗最多5处寡转移病灶的疗效：非随机对照人群二期临床试验SABR-5的长期结果分析
Curtis Leclerc,Sarah Baker,Will Jiang et al.
Curtis Leclerc et al.
Purpose/objective(s): The use of SABR for oligometastatic cancer is expanding, but prospective long-term survival data are limited. This study reports long-term secondary outcomes of overall survival (OS), progression-fre...
International Radiosurgery Oncology Consortium of the Kidney (IROCK) Contouring Guidelines for Renal Cell Carcinoma treated with Stereotactic Ablative Radiotherapy [0.03%]
肾脏国际放射外科肿瘤学会（IROCK）立体定向消融放疗治疗肾细胞癌勾画指南
Aneesh Dhar,Shankar Siva,Vivian S Tan et al.
Aneesh Dhar et al.
Introduction: Stereotactic ablative body radiotherapy (SABR) is an emerging indication for localized renal cell carcinoma (RCC), yet there is a need for standardizing contouring practices, as accurate target delineation i...
Phase I Clinical Trial of De-escalated Conformal Radiation Expedited Sequentially with Chemotherapy for Advanced Endometrial Cancer (DeCRESCEndo) [0.03%]
降阶调强放疗序贯化疗治疗晚期子宫内膜癌的I期临床试验(DeCRESCEndo)
Joshua P Schiff,Silpa Raju-Salicki,Tyler R McKinnish et al.
Joshua P Schiff et al.
Introduction: The safety and efficacy of hypofractionated-radiation (hypo-RT) and chemotherapy for locally advanced endometrial cancer is unknown. We evaluated the safety of hypo-RT sequenced after chemotherapy for patien...
NImmuno-radiobiology: Effects of radiation therapy on immune cells, tumor microenvironment, susceptibility of tumor cells to immune-mediated destruction, and anti-tumor immunity [0.03%]
免疫放射生物学：放射治疗对免疫细胞、肿瘤微环境、肿瘤细胞的免疫原性及抗肿瘤免疫的影响
Yujuan Wang,Tracy Berg,Alexander W Verona et al.
Yujuan Wang et al.
Immuno-radiobiology is an interdisciplinary field exploring the interactions between ionizing radiation therapy, the tumor-immune microenvironment, and the immune system. The immune response to radiation is an important contributor to the e...
Uterine Transposition Prior to Pelvic Radiation: First Canadian Center [0.03%]
放射治疗前的子宫复位术：加拿大首个中心经验
Reitan Ribeiro,Gabriel Levin,Thierry Muanza et al.
Reitan Ribeiro et al.
Pretreatment Chromosomal Instability Correlates With Radiation Sensitivity in Squamous Cell Cancers [0.03%]
鳞状细胞癌中化疗引起的染色体不稳定与放射敏感性相关
Pippa F Cosper,Maha Paracha,Kathryn M Jones et al.
Pippa F Cosper et al.
Purpose: Continuous chromosome missegregation over successive mitotic divisions, known as chromosomal instability (CIN), is common in cancer. Though it has been associated with treatment resistance and poor prognosis, inc...
Deformable Point Cloud Registration-Based Bidirectional Local Distance (DPCR-BLD): A Methodology for Systematic Evaluation and Visualization of Local Disagreements in Clinical Auto-Contouring [0.03%]
基于可变形点云配准的双向局部距离(DPCR-BLD):一种临床自动勾画局部分歧的系统评价和可视化方法学
Jingwei Duan,Libing Zhu,Rex A Cardan et al.
Jingwei Duan et al.
Background: Variability in auto-segmentation can arise from the training data, leading to disagreements with clinical practice. The anisotropic and localized nature of disagreements between two contours makes them challen...
The KIM real-time prostate cancer IGRT technology journey: From clinical trials to your clinic [0.03%]
从临床试验到临床应用的KIM前列腺癌IGRT技术之旅
Paul J Keall,Jeremy Booth,Thomas Eade et al.
Paul J Keall et al.
Purpose: SBRT schedules for prostate cancer are emerging as a standard treatment approach. However, although high efficacy is achieved in clinical trials, additional efforts at accurate treatment delivery are necessary to...